Bernard W. Futscher
Affiliations: | University of Arizona, Tucson, AZ |
Area:
Pharmacology, Cell Biology, ToxicologyGoogle:
"Bernard Futscher"Children
Sign in to add traineeJonathan E. Dodge | grad student | 2000 | University of Arizona |
Marc M. Oshiro | grad student | 2000 | University of Arizona |
Ryan J. Wozniak | grad student | 2006 | University of Arizona |
Damian J. Junk | grad student | 2008 | University of Arizona |
Paul L. Severson | grad student | 2013 | University of Arizona |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bixby B, Vrba L, Lenka J, et al. (2023) Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid. Research Square |
Vrba L, Futscher BW, Oshiro M, et al. (2022) Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease. Clinical Epigenetics. 14: 28 |
Munugala N, Hammad H, Vrba L, et al. (2020) Detection of pancreatic cancer using a novel blood-based DNA methylation signature. Journal of Clinical Oncology. 38: e15546-e15546 |
Vrba L, Futscher BW. (2019) DNA methylation changes in biomarker loci occur early in cancer progression. F1000research. 8: 2106 |
Vrba L, Oshiro MM, Kim SS, et al. (2019) DNA methylation biomarkers discovered detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 1-12 |
Vrba L, Futscher BW. (2019) DNA methylation changes in biomarker loci occur early in cancer progression [version 1; peer review: 2 approved] F1000research. 8: 2106 |
Vrba L, Futscher BW. (2018) Epigenetic silencing of lncRNA in 16 TCGA cancer types. F1000research. 7: 211 |
Vrba L, Futscher BW. (2017) A suite of DNA methylation markers that can detect most common human cancers. Epigenetics. 1-38 |
Vrba L, Futscher BW. (2017) Epigenetic Silencing of Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. Journal of Breast Cancer. 20: 198-202 |
Black SA, Nelson AC, Gurule NJ, et al. (2016) Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression. Oncogene |